dpp4 vs sglt2 vs glp-1 SGLT-2 inhibitors, receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study Clinical Use of DPP-4 Inhibitors
Description
Remove patch and discard
It is not approved yet, but the data is starting to demand attention
The gut hormones, ...
Get Started
The pharmaceutical boom in weight-loss drugs has put companies like Novo Nordisk and Eli Lilly in ever-fiercer competition
The attendee collapsed at the presidents drug pricing event.
